Summit Therapeutics Inc. (SMMT) — DEF 14A Filings
All DEF 14A filings from Summit Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Summit Therapeutics Files 2024 DEF 14A
— Apr 29, 2025 Risk: low
Summit Therapeutics Inc. filed a DEF 14A on April 29, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and board me -
Summit Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 25, 2024 Risk:
Summit Therapeutics Inc. (SMMT) filed a Proxy Statement (DEF 14A) with the SEC on April 25, 2024. Annual meeting to be held virtually on June 14, 2024, at 9:00
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX